Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.
Strupp C, Gattermann N, Giagounidis A, Aul C, Hildebrandt B, Haas R, Germing U.
Leuk Res. 2003 May;27(5):397-404. doi: 10.1016/s0145-2126(02)00220-5.
Refractory anemia with excess of blasts: increased survival when treated with cyclophosphamide, methotrexate and 6-mercaptopurine.
Majluf-Cruz A, Hurtado R, Vargas-Vorackova F, Labardini-Méndez J.
Eur J Haematol. 1999 Apr;62(4):213-8. doi: 10.1111/j.1600-0609.1999.tb01749.x.
Biological characterization of refractory anemia with excess of blasts.
Maiolo AT, Foa P, Pagetti D, Baldini L, Mozzana R, Ortolani S, Colantoni A, Lombardi L, Lavezzi AM, Polli EE.
Haematologica. 1987 Nov-Dec;72(6 Suppl):126-9.
Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.
Salim O, Toptas T, Avsar E, Yucel OK, Ozturk E, Ferhanoglu B, Geduk A, Mehtap O, Tombak A, Tiftik EN, Deveci B, Kurtoglu E, Kara O, Atagunduz IK, Tuglular TF, Undar L.
Leuk Res. 2016 Jun;45:82-9. doi: 10.1016/j.leukres.2016.04.003. Epub 2016 Apr 11.
Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study.
Kikuchi A, Hasegawa D, Ohtsuka Y, Hamamoto K, Kojima S, Okamura J, Nakahata T, Manabe A; Japanese Paediatric Myelodysplastic Syndrome (MDS) Study Group.
Br J Haematol. 2012 Sep;158(5):657-61. doi: 10.1111/j.1365-2141.2012.09210.x. Epub 2012 Jun 26.
Re-evaluation of refractory anemia with excess blasts in transformation.
Ohyashiki K, Nishimaki J, Shoji N, Miyazawa K, Kimura Y, Ohyashiki JH.
Leuk Res. 2001 Nov;25(11):933-9. doi: 10.1016/s0145-2126(01)00054-6.
Refractory anemia with excess of blasts in transformation. Clinical, hematologic, and cytogenetic findings in nine patients.
Smadja N, Krulik M, de Gramont A, Gonzalez-Canali G, Audebert AA, Debray J.
Cancer Genet Cytogenet. 1989 Oct 1;42(1):55-65. doi: 10.1016/0165-4608(89)90008-3.
Trisomy 14 in refractory anemia with excess of blasts in transformation.
Haas OA, Jäger U, Ambros P, Pabinger I.
Cancer Genet Cytogenet. 1987 Dec;29(2):315-8. doi: 10.1016/0165-4608(87)90242-1.
Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
Wei J, Zhou XF, Zhao F, Zhou JF, Chen Y.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Feb;17(1):111-6.
Refractory anemia with excess of blasts in transformation hematologic and clinical study of 52 patients.
Michels SD, Saumur J, Arthur DC, Robison LL, Brunning RD.
Cancer. 1989 Dec 1;64(11):2340-6. doi: 10.1002/1097-0142(19891201)64:11<2340::aid-cncr2820641125>3.0.co;2-i.
